{"altmetric_id":3633330,"counts":{"readers":{"mendeley":15,"citeulike":0,"connotea":0},"total":{"posts_count":5},"wikipedia":{"unique_users_count":5,"unique_users":["en:36175312","en:36175064","en:36174213","en:36174254","en:36174167"],"posts_count":5}},"citation":{"altmetric_jid":"4f6fa4eb3cf058f61000284e","authors":["Rae R Matsumoto","Kari A McCracken","Michele J Friedman","Buddy Pouw","Brian R De Costa","Wayne D Bowen"],"doi":"10.1016\/s0014-2999(01)00968-2","endpage":"174","first_seen_on":"2015-02-14T20:21:17+00:00","issns":["00142999"],"issue":"2-3","journal":"European Journal of Pharmacology","last_mentioned_on":1400073060,"links":["http:\/\/dx.doi.org\/10.1016\/S0014-2999(01)00968-2","http:\/\/dx.doi.org\/10.1016\/s0014-2999(01)00968-2"],"pubdate":"2001-05-01T00:00:00+00:00","scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"163","title":"Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting \u03c31 receptors produce anti-cocaine effects in mice","type":"article","volume":"419","mendeley_url":"http:\/\/www.mendeley.com\/research\/conformationally-restricted-analogs-bd1008-antisense-oligodeoxynucleotide-targeting-1-receptors-prod"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":4309745,"mean":4.9743409911825,"rank":988757,"this_scored_higher_than_pct":63,"this_scored_higher_than":2753027,"rank_type":"exact","sample_size":4309745,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":144372,"mean":8.4115017143334,"rank":42758,"this_scored_higher_than_pct":69,"this_scored_higher_than":99775,"rank_type":"exact","sample_size":144372,"percentile":69},"this_journal":{"total_number_of_other_articles":1971,"mean":2.2020873096447,"rank":150,"this_scored_higher_than_pct":47,"this_scored_higher_than":930,"rank_type":"exact","sample_size":1971,"percentile":47},"similar_age_this_journal_3m":{"total_number_of_other_articles":38,"mean":1.2662162162162,"rank":3,"this_scored_higher_than_pct":92,"this_scored_higher_than":35,"rank_type":"exact","sample_size":38,"percentile":92}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":4,"Student  > Ph. D. Student":3,"Student  > Master":1,"Professor":5},"by_discipline":{"Medicine and Dentistry":1,"Chemistry":2,"Psychology":2,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":4,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"mendeley":{"US":2,"ES":1}}},"posts":{"wikipedia":[{"title":"BD1008","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=498344181#altmetric_citation_1","license":"public","citation_ids":[3633330,3633334],"posted_on":"2012-06-19T14:27:44+00:00","summary":"BD1008 or N--N-methyl-1-pyrrolidineethanamine is a selective sigma receptor antagonist, with a reported binding affinity of Ki = 2 \u00b1 1 nM for the sigma-1 receptor and 4 times selectivity over the sigma-2 receptor.","page_url":"http:\/\/en.wikipedia.org\/?curid=36175312","wiki_lang":"en","author":{"name":"BaeyerDrewson","url":"http:\/\/en.wikipedia.org\/wiki\/User:BaeyerDrewson"}},{"title":"BD1018","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=608540776#altmetric_citation_0","license":"public","citation_ids":[3633330],"posted_on":"2014-05-14T13:10:25+00:00","summary":"BD1018 or (S)-2-octahydropyrrolopyrazine is a selective sigma receptor ligand, with a reported binding affinity of Ki = 5 \u00b1 0.7 nM for the sigma-1 receptor and approximately 10 times selectivity over the sigma-2 receptor.","page_url":"http:\/\/en.wikipedia.org\/?curid=36175064","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}},{"title":"LR132","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=608540771#altmetric_citation_0","license":"public","citation_ids":[3633330],"posted_on":"2014-05-14T13:10:24+00:00","summary":"LR132 or (+)-3,4-dichloro-N-benzeneethanamine is a selective sigma receptor antagonist, with a reported binding affinity of Ki = 2 \u00b1 0.1 nM for the sigma-1 receptor and more than 350 times selectivity over the sigma-2 receptor.","page_url":"http:\/\/en.wikipedia.org\/?curid=36174213","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}},{"title":"BD1063","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=608540848#altmetric_citation_2","license":"public","citation_ids":[3633330],"posted_on":"2014-05-14T13:11:00+00:00","summary":"BD1063 or 1--4-methylpiperazine is a selective sigma receptor antagonist, with a reported binding affinity of Ki = 9 \u00b1 1 nM for the sigma-1 receptor and more than 49 times selectivity over the sigma-2 receptor.","page_url":"http:\/\/en.wikipedia.org\/?curid=36174254","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}},{"title":"BD1031","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=608540767#altmetric_citation_0","license":"public","citation_ids":[3633330],"posted_on":"2014-05-14T13:10:22+00:00","summary":"BD1031 or (R)-2-octahydropyrrolopyrazine is a selective sigma receptor agonist, with a reported binding affinity of Ki = 1 \u00b1 0.2 nM for the sigma-1 receptor and 80 times selectivity over the sigma-2 receptor.","page_url":"http:\/\/en.wikipedia.org\/?curid=36174167","wiki_lang":"en","author":{"name":"Rjwilmsi","url":"http:\/\/en.wikipedia.org\/wiki\/User:Rjwilmsi"}}]}}